AML with BCR::ABL1 is much less described but has been associated with a lower frequency of ACA and with a unique gene signature including deletion in IKZF1, CDKN2A and/or in the immunoglobulin and T cell receptor genes [9]. The gene discussed is BCR; the disease is acute myeloid leukemia.